A new nano-based drug delivery technology could outwit tuberculosis (TB)—one of humanity's most ancient diseases.
India's top drug regulator cited insufficient evidence of efficacy in the two studies conducted by Serum Institute and ICMR.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback